Angiogenesis inhibitor

Details Angiogenesis inhibitor Angiogenesis inhibitor

A - Human Necessities

61

K

A61K 31/7004 (2006.01) A61K 31/7024 (2006.01) A61K 31/7028 (2006.01) A61P 9/00 (2006.01) A61P 35/04 (2006.01)

Patent

CA 2432536

Angiogenesis inhibitors and drugs inhibiting the tumor metastasis accelerated by TP which comprise, as the active ingredient, at least one compound selected from the group consisting of 2-deoxy-L-ribose, 2-deoxy-L-ribose derivatives methylated and/or acylated at the hydroxyl group and 2-deoxy-D-ribose derivatives methylated and/or acylated at the hydroxyl group.

L'invention concerne des inhibiteurs d'angiog~n­se et des m~dicaments inhibant la m~tastase tumorale acc~l~r~e par TP, qui poss­dent comme principe actif au moins un compos~ s~lectionn~ dans le groupe constitu~ par 2-d~oxy-L-ribose, des d~riv~s de 2-d~oxy-L-ribose m~thyl~s et/ou acyl~s au niveau du groupe hydroxyle, et des d~riv~s de 2-d~oxy-D-ribose m~thyl~s et/ou acyl~s au niveau du groupe hydroxyle.

Affiliated with

Also associated with

Rating

Angiogenesis inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiogenesis inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiogenesis inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1816244